|
OMIM |
Link |
Information gain |
01 |
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.00272161
|
|
|
TAPVR1
|
[NCBI]
|
0.000607858
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
0.000588308
|
|
|
DHS
|
[NCBI]
|
0.000451673
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
0.000400867
|
|
|
SLE
|
[NCBI]
|
0.000395596
|
|
|
proteus syndrome
|
[NCBI]
|
0.000326916
|
|
|
behcet syndrome
|
[NCBI]
|
0.000317551
|
|
|
thrombophilia
|
[NCBI]
|
0.000308993
|
|
|
factor v deficiency
|
[NCBI]
|
0.000153128
|
|
|
HRG
|
[NCBI]
|
0.00013276
|
|
|
sickle cell anemia
|
[NCBI]
|
0.000116982
|
|
|
MTHFR
|
[NCBI]
|
0.000110101
|
|
|
PF4
|
[NCBI]
|
9.29839e-05
|
|
|
PROS1
|
[NCBI]
|
8.00014e-05
|
|
|
aspirin resistance
|
[NCBI]
|
7.7463e-05
|
|
|
F2
|
[NCBI]
|
7.17925e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
6.57247e-05
|
|
|
protein z-dependent protease inhibitor precursor
|
[NCBI]
|
6.32662e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
6.17564e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
6.10572e-05
|
|
|
TFPI
|
[NCBI]
|
5.75499e-05
|
|
|
F2RL3
|
[NCBI]
|
5.46954e-05
|
|
|
MB
|
[NCBI]
|
5.32999e-05
|
|
|
HCF2
|
[NCBI]
|
5.01906e-05
|
|
|
THBD
|
[NCBI]
|
4.47654e-05
|
|
|
PLAT
|
[NCBI]
|
4.12869e-05
|
|
|
F3
|
[NCBI]
|
3.22727e-05
|
|
|
CAT
|
[NCBI]
|
2.9175e-05
|
|
|
CPB2
|
[NCBI]
|
2.56594e-05
|
|
|
RA
|
[NCBI]
|
2.37715e-05
|
|
|
BCHE
|
[NCBI]
|
2.06285e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.52622e-05
|
|
|
CP
|
[NCBI]
|
1.42365e-05
|
|
|
MPO
|
[NCBI]
|
1.3594e-05
|
|
|
ACE
|
[NCBI]
|
1.24185e-05
|
|
|
PWS
|
[NCBI]
|
1.03214e-05
|
|
|
XDH
|
[NCBI]
|
9.06908e-06
|
|
|
PTHLH
|
[NCBI]
|
7.37989e-06
|
|
|
NPPA
|
[NCBI]
|
3.49789e-06
|
|
|
VEGF
|
[NCBI]
|
3.23592e-06
|
|
|
KLK3
|
[NCBI]
|
2.05912e-06
|
|
|
TNF
|
[NCBI]
|
1.8536e-06
|
|
|
HGF
|
[NCBI]
|
7.45573e-07
|
|
|
AVP
|
[NCBI]
|
3.49552e-07
|
|
|
CEACAM5
|
[NCBI]
|
1.58335e-07
|
|
|
APOE
|
[NCBI]
|
1.31068e-07
|
|
|
PCNA
|
[NCBI]
|
9.67348e-08
|
|